OncoZenge extends payment deadline for remaining SEK 10.1 million private placement proceeds
Reuters2026/07/31 14:31- OncoZenge extended the payment deadline for about SEK 10.1 million of remaining proceeds in a directed share issue to Sichuan Yangtian Bio-Pharmaceutical.
- Payment was due by July 31, 2026; the deadline moved to Aug. 7, 2026.
- The investor cited an expired SAFE currency exchange certificate as the cause; renewal is in progress.
- OncoZenge expects payment by the new deadline; it will update the market once funds are received and the issue is registered.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OpenAI enterprise business shows "strong momentum," CFO: 32% month-on-month growth in July
According to media reports, OpenAI CFO Sarah Friar stated that the company's enterprise business has performed "very strongly" recently; OpenAI's overall annualized revenue run rate in July increased by 20% compared to the previous month, with enterprise business up 32% month-on-month, outpacing the growth of personal consumer business.
Adobe names Anil Chakravarthy CEO effective Dec. 1, 2026
Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $264,110
Crypto prices
More
